Controlled release, antimicrobial activity, and oral mucosa irritation of cetylpyridinium chloride-montmorillonite incorporated in a tissue conditioner

Dent Mater J. 2022 Feb 1;41(1):142-149. doi: 10.4012/dmj.2021-155. Epub 2021 Sep 23.

Abstract

This study examined the controlled release of cetylpyridinium chloride (CPC) from a tissue conditioner (TC) containing CPC-montmorillonite (CPC-Mont), the associated antimicrobial activity, and oral mucosa irritation. The CPC release test was performed daily for 28 days in three test solutions: distilled water, 0.2 M NaCl, and 0.2 M HCl. The antimicrobial activities for 7, 14, 21, and 28 days against Candida albicans, Staphylococcus aureus, and Streptococcus mutans were assessed according to the JIS Z 2801/ISO 22196 standard. An oral mucosa irritation test was conducted using cheek pouches in five male hamsters according to the ISO 10993-10:2010 standard. The amount of CPC released each day and the cumulative amount released over 28 days (6.12 mg) were less than the daily safe maximum of sore throat medicines (8 mg). Additionally, TC with CPC-Mont could sustain antimicrobial activity against adherent bacteria for 14 days and has no oral mucosa irritation potential.

Keywords: Antimicrobial; Cetylpyridinium chloride (CPC); Oral mucosa irritation; Release test; Tissue conditioner.

MeSH terms

  • Anti-Infective Agents, Local* / toxicity
  • Bentonite / toxicity
  • Cetylpyridinium* / toxicity
  • Delayed-Action Preparations
  • Humans
  • Male
  • Mouth Mucosa

Substances

  • Anti-Infective Agents, Local
  • Delayed-Action Preparations
  • Bentonite
  • Cetylpyridinium